Invention Grant
- Patent Title: High concentration antibody formulations
-
Application No.: US16045928Application Date: 2018-07-26
-
Publication No.: US11040102B2Publication Date: 2021-06-22
- Inventor: Timothy David Osslund
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K9/08 ; A61K39/00 ; A61K47/14 ; A61K9/00 ; A61K47/12 ; A61K47/24
Abstract:
Discloses herein are high concentration antibody formulations comprising an anti-sclerostin immunoglobulin and an acetate salt and/or an acetate buffer and methods of use.
Public/Granted literature
- US20190022230A1 High Concentration Antibody Formulations Public/Granted day:2019-01-24
Information query
